Related Experiment Video
Updated: Apr 6, 2026

14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
17.2K
[Poly(β-amino esters)-based barriers for tumor targeted delivery system].
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|July 31, 2015
Summary
Poly(β-amino esters) (PBAE) show promise as pH-sensitive, low-toxicity drug carriers for cancer therapy. Their structural versatility and ease of synthesis make them ideal for targeted drug delivery systems.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Nanomedicine
Background:
- Poly(β-amino esters) (PBAE) are a class of polymers with inherent pH-sensitivity and low toxicity.
- Their facile synthesis and structural tunability offer significant advantages for biomedical applications.
- PBAE are being explored as advanced drug delivery vehicles, particularly for cancer treatment.
Purpose of the Study:
- To review the structural characteristics of PBAE relevant to drug delivery.
- To examine the drug targeting properties of PBAE in tumor delivery systems.
- To highlight the diverse applications and drug loading capabilities of PBAE for cancer therapy.
Main Methods:
- Literature review focusing on PBAE synthesis and properties.
- Analysis of studies investigating PBAE in tumor-targeted drug delivery.
- Compilation of data on various anti-cancer drugs encapsulated within PBAE.
Main Results:
- PBAE exhibit favorable properties like pH-sensitivity, low toxicity, and structural diversity.
- Their synthetic accessibility facilitates the development of tailored drug delivery systems.
- Various anti-cancer drugs have been successfully loaded into PBAE for targeted delivery.
Conclusions:
- PBAE are highly promising candidates for developing effective tumor-targeted drug delivery systems.
- Their unique properties enable efficient drug release and enhanced therapeutic outcomes.
- Further research into PBAE holds significant potential for advancing cancer nanomedicine.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
114
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
114
Modified-Release Drug Delivery Systems: Site-Targeted
112
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
112
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Modified-Release Drug Delivery Systems: Rate-Programmed II
91
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
91
Modified-Release Drug Delivery Systems: Classification
264
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
264
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K

